Systemic Lupus Erythematosus Clinical Trials in La Palma, California

4 studies are recruiting for systemic lupus erythematosus in La Palma, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

    This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE. The study tests different doses of BI 3000202 and aims to find the best dose for people with this condition. Participants are pu…

    Stage
    Phase 2
    Ages
    18 to 74
    Site
    Arthritis & Osteoporosis Medical Center, Inc - La Palma, La Palma, California
    Locations
    140 in total
    Run by
    Boehringer Ingelheim

    See if you can join NCT07409181 on ClinicalTrials.gov

  2. A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

    The purpose of the SUNFLOWER study is to describe clinical outcomes, including DORIS remission, achieved following the initiation of anifrolumab 120 mg SC once weekly (QW) as add-on therapy to an anti-malarial, with or without GC; in patients not in LLDAS at enrolment. Patients will be naïve to any…

    Stage
    Phase 3
    Ages
    18 to 70
    Site
    Research Site, La Palma, California
    Locations
    107 in total
    Run by
    AstraZeneca

    See if you can join NCT07430306 on ClinicalTrials.gov

  3. A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

    The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.

    Stage
    Phase 3
    Ages
    16 and older
    Site
    Sl0044 50275, La Palma, California
    Locations
    242 in total
    Run by
    UCB Biopharma SRL

    See if you can join NCT06617325 on ClinicalTrials.gov

  4. Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

    The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).

    Stage
    Phase 3
    Ages
    12 to 100
    Site
    Advanced Medical Research, La Palma, California
    Locations
    143 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT06133972 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.